Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

AutoImmune updates clinical program for oral RA product

Jan. 17, 1997

Genelabs completes first pivotal trial on SLE Rx

Jan. 16, 1997

Chiroscience investigates MMP/TNF inhibitors

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

Chiroscience reports new peptidyl compounds for treating degenerative diseases

Jan. 14, 1997

Phase I ConXn data reported

Jan. 10, 1997

Chondrex license agreement option exercised

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...